Mandatory trans fat labeling regulations and nationwide product reformulations to reduce trans fatty acid content in foods contributed to lowered concentrations of trans fat in Canadian women's breast milk samples collected in [2009][2010][2011] 1-3 WM Nimal Ratnayake, Eleonora Swist, Rana Zoka, Claude Gagnon, William Lillycrop, and Peter Pantazapoulos ABSTRACT Background: Recent efforts in Canada to reduce industrial trans fatty acids (TFAs) in foods include mandated inclusion of TFA content on food labels and recommendations by Health Canada that encourage the food industry to voluntarily limit TFA content in all vegetable oils and soft margarines and in all other prepackaged foods to ,2% and ,5% of total fat, respectively. Objective: To assess the impact of these efforts, we measured the concentration of TFAs in human breast milk samples. Design: The TFA content in 639 breast milk samples collected in 2009, 2010, and 2011 from breastfeeding mothers in 10 major cities across Canada was analyzed by gas chromatography. Results: The mean (6SD) TFA contents were 2.7 6 0.9% (n = 153, range: 1.4-7.2%), 2.2 6 0.7% (n = 309, range: 1.0-6.8%), and 1.9 6 0.5% (n = 177, range: 0.9-3.4%) of total milk fat for samples collected in 2009, 2010, and 2011, respectively. These values are considerably lower than the value of 7.2 6 3.0% (range: 0.1-17.2%) found previously for Canadian human milk in 1992. On the basis of a linear correlation between the percentage of TFAs in the diet and human milk fat established by Craig-Schmidt et al, and assuming that 30% of energy of a lactating mother's diet is derived from fat, we estimated from the TFA human milk fat data that TFA intake of Canadian breastfeeding mothers was 0.9%, 0.5%, and 0.3% of total energy in 2009, 2010, and 2011, respectively. These estimated values are lower than the WHO's maximum recommended intake of 1% of total energy for a healthy diet. Conclusions: The results suggest that the trans fat labeling regulations introduced in 2003 and recommendations by Health Canada in 2007 instructing the food manufacturers and restaurants to limit TFAs in foods have resulted in significant reductions in TFAs in the diets of Canadian breastfeeding mothers and their breast milk.
INTRODUCTION
Partially hydrogenated vegetable oils (PHVOs) 4 have traditionally been used in Canada in frying and in the preparation of margarines and breads, as well as in a number of other processed foods (1) (2) (3) (4) (5) (6) (7) (8) . Partial hydrogenation results in the formation of trans fatty acids (TFAs). Consumption of TFAs increases the risk of coronary artery disease (CAD) (9, 10) .
In the 1990s, it was estimated, through analysis of TFA content in human milk, that the average TFA intake in Canada was 8.4 g/d or 3.7% of total energy (11) . Since the early 2000s, a number of measures to limit the dietary concentrations of TFAs have been implemented in Canada. In 2003, the Canadian government passed legislation requiring mandatory TFA food labeling, which came into force by 2005 (8, 12) . Furthermore, in 2007, Health Canada called on the food industry to voluntarily reduce concentrations of TFAs to ,2% of total fat in vegetable oils and soft spreadable margarines and to ,5% of total fat in all other prepackaged foods. These limits do not apply to food products for which the fat originates exclusively from ruminant meat or dairy products. It was estimated that these limits, established by a Canadian task force on trans fats (13) , would result in a reduction in the TFA concentrations in the Canadian diet to the WHO-recommended limit of ,1% of total energy (14) .
Health Canada has been performing a national assessment of the fatty acid profile of prepackaged foods and restaurant foods to closely monitor the efforts of industry to ensure that substantial progress is being made to achieve the recommended limits. The results have shown that food companies have made substantial progress in reducing the TFA content in their products to below the 2% or 5% limits (15) (16) (17) . The most important implication of these changes was that, by 2008, the average intake of TFAs in Canada significantly dropped from the high value of 8.4 g/d in the mid-1990s (18) to 3.4 g/d (or 1.4% of total energy) (16) .
Breast milk is a convenient biological sample for establishing dietary concentrations of TFAs (19) (20) (21) . This is because the TFA content in human milk reflects the mother's previous-day diet.
Craig-Schmidt et al (20) generated a linear correlation between the percentage of TFAs in human milk fat and the percentage of TFAs in mothers' previous-day dietary fat.
Earlier studies detected very high concentrations of TFAs in Canadian human milk (18, 21, 22) . National-level biomonitoring of human milk for TFAs would allow a time trend analysis and also help to further assess the impact of TFA labeling regulations and Health Canada's recommendation to the industry for a voluntary reduction of TFAs in prepackaged and restaurant foods. In this study, we determined the concentrations of TFAs in milk samples collected from breastfeeding mothers nationwide for 3 consecutive years from 2009 to 2011.
SUBJECTS AND METHODS

Subjects
The human milk samples used in this study were from the MIREC (Maternal-Infant Research on Environmental Chemicals) study (23) . The MIREC study was established to obtain Canadian biomonitoring data for pregnant women and their infants. One objective of the MIREC study was to measure selected known or perceived beneficial substances in human milk, such as nutrients and minerals (eg, vitamins D and E, complete fatty acid profile). Full details of the MIREC study design and study population have been published recently (23) . Recruitment of the subjects for the study started in February 2008.
In brief, 2001 women consented to participate in the MIREC Research Platform, and from this cohort, 1017 women provided breast milk samples. Mothers were asked to express 185 mL of mature milk (2-8 wk postpartum) manually after or during nursing to obtain an optimum combination of fore and hind milk. Samples were stored in the refrigerator for a maximum of 72 h or in the home freezer for time exceeding 72 h. The milk samples were then shipped on ice to Health Canada in Ottawa. Each milk sample was partitioned into smaller volumes to provide each participating laboratory at Health Canada with the amount of milk necessary to perform the required analysis. For fatty acid analysis, 10 mL was portioned into aliquots and stored in amber glass bottles at 2808C until analysis.
From the 1017 samples collected, 639 were randomly used in this study for the analysis of milk fatty acid composition. The 639 samples were from the 3-y consecutive collection period of 2009 (n = 153), 2010 (n = 309), and 2011 (n = 177) from mothers living in 10 major cities across Canada. The breakdown according to the 10 cities was as follows: Calgary (n = 15), Halifax (n = 95), Hamilton (n = 75), Kingston (n = 65), Montreal (n = 96), Ottawa (n = 57), Sudbury (n = 30), Toronto (n = 94), Vancouver (n = 73), and Winnipeg (n = 39). Compared with our previous nationwide study of 198 human milk samples in 1992 (21) , it was thought that the 639 samples (average of 213 samples/y) would be adequate for a time trend comparison of TFA concentrations.
Fatty acid analysis
Milk samples were thawed at room temperature, and fat from a 1-g weighed subsample was extracted according to AOAC Official Method 996.06 (24) with some modifications. Briefly, to the 1-g sample, 1 mL 95% ethanol, 2 mL distilled water, and 1 mL ammonium hydroxide were added, mixed for about 2 min, and heated in a shaking water bath at 70-808C for 10 min. After allowing the contents to cool to room temperature, 12 mL diethyl ether was added and the contents mixed for 5 min. Furthermore, 12 mL petroleum ether was added and the contents mixed again for another 5 min. The samples were then centrifuged for 2 min at 120 3 g and the organic solvent layer collected and evaporated to dryness under a stream of nitrogen. The extracted fat was dissolved in 2 mL toluene and converted to fatty acid methyl esters by using 1 mL of BF 3 -CH 3 OH.
The fatty acid methyl esters in hexane were analyzed on a gas chromatogram (GC) (Agilent 6890N system with an auto injector; Agilent) that was fitted with a flame ionization detector and a 100-m 3 0.25-mm (0.2-mm film) capillary column coated with SP-2560 (Supelco). The initial column oven temperature was 1808C, followed by 2 ramps at 38 min (2158C) and 69 min (2258C). The injector and the detector temperatures were 2508C. Ultra-high-purity hydrogen was the carrier gas and run at a flow rate of 0.8 mL/min. Peaks were identified by comparison with the GC traces published in the American Oil Chemists' Society Official Method Ce 1h-05 (25) and by Ratnayake (26) . Identifications were further established by comparison with known fatty acid methyl ester standards (Nu-Chek Prep and Sigma). The fatty acid composition, as a percentage of total fatty acids, was calculated according to the American Oil Chemists' Society Official Method Ce 1h-05 (25) . The direct GC procedure employed here gives a good resolution of all the fatty acids, including the cis and trans isomers of oleic acid (18:1 or octadecenoic acid), except for the minor overlap of 9c-18:1 with 15t-18:1 (25) (26) (27) (28) . Because of this overlap, the concentration of 15t-18:1 could not be measured from the direct GC procedure, but it is included with 9c-18:1 in the fatty acid composition data shown in Table 1 . Because 15t-18:1 is always a minor component in most dietary fat (,0.1% of total fatty acids), the error in grouping 15t-18:1 with 9c-18:1 has only a minimal impact on the calculation of the total TFAs and 9c-18:1 (26) .
Statistical analysis
Data are expressed as mean 6 SD and ranges (minimummaximum values). Analysis of variance followed by the HolmSidak test was used for statistical evaluation of significant differences between fatty acids. Relations were declared significant at P # 0.05. Statistical analyses were performed by using SigmaPlot version 11.2 (Systat Software).
RESULTS
The composition of major SFAs; cis-MUFAs; n26 and n23 PUFAs; trans isomers of octadecenoic acid (18:1t), linoleic acid (18:2t), and a-linolenic acid (18:3t); and the totals of these fatty acid classes are shown in Table 1 for milk samples collected in 2009, 2010, and 2011. For comparison purposes, our previously published fatty acid data of Canadian human milk samples collected in 1992 nationwide (21) are also shown in Table 1 . The total TFA concentration decreased from 1992 to 2011, such that the milk collected in 2011 was 74% lower in TFAs than the milk collected in 1992 (21) . The mean concentration of total TFAs in milk collected in 2011 was 1.9 g/100 g of human milk fatty acids (range: 0.9-3.9 g/100 g milk fatty acids), whereas the milk collected in 1992 was 7.2 g/100 g milk fatty acids (range: 0.1-17.2 g/100 g milk fatty acids). The total TFA concentration also gradually and significantly decreased from 2009 to 2011. From 2009 to 2010, the total TFAs decreased from 2.7 to 2.2 g/100 g milk total fatty acids (ie, a decrease of 18%), and by 2011, it decreased further to 1.9 g/100 g milk fatty acids, an additional decrease of 14%. From 2009 to 2011, the total TFA concentration decreased by 30%. As illustrated in Table 1 , the decrease in the mean concentration of total TFAs was associated with a decrease in the minimum-maximum range of total TFAs. The decrease in total TFAs is primarily attributable to a decrease of the 18:1t isomer group. Significant regional differences in the TFA concentrations as well as the other fatty acids were not observed in this study (data not shown).
The decrease of TFAs from 1992 to 2009 and from 2009 to 2011 was associated with significant increases in oleic (9c-18:1), linoleic (18:2n26), and a-linolenic (18:3n23) acids (Table 1 ).
The SFA concentrations remained unchanged for the 3 consecutive years from 2009 to 2011 (Table 1 ) and are not different from the 1992 collection, except for the slightly higher value for the 2010 samples.
DISCUSSION
The most striking finding of this study is that the concentration of total TFAs in Canadian human milk decreased gradually and significantly for the 3 consecutive years from 2009 to 2011. Furthermore, the TFA concentrations for these 3 y are considerably lower compared with our previous nationwide human milk study in 1992 (21) . These concentrations are also low compared with those reported by Innis and colleagues for human milk samples collected in 1998 (22) 1 Values are weight percentages of total fatty acids, expressed as means 6 SDs; ranges in parentheses. Means in a row not sharing a common superscript letter are significantly different, P # 0.05 (Holm-Sidak test). LC, long chain; TFA, trans fatty acid.
2 The fatty acid data are from our previous study of human milk collected and analyzed in 1992 (21 collected in 2011, which is the most recent Canadian nationwide collection of human milk, was 1.9 g/100 g of milk fatty acids, which is 74% lower than the concentration of 7.2 g/100 g milk fatty acids found for the samples collected from different regions of Canada in 1992. These considerable differences most likely reflect the low concentration of TFAs in the current Canadian diet and, therefore, in current Canadian foods compared with the Canadian diet and foods sold in the 1990s and the mid-2000s (4-6, 8, 29) . The retail prepackaged foods that were available in the Canadian market in the 1990s and to mid-2000s contained very high concentrations of TFAs compared with those foods sold in Canada in recent years (15, 16) . The mandatory TFA food labeling regulation of prepackaged foods that came into effect in 2005 (12) and Health Canada's recommendation in 2007, based on the report of the Canadian task force on trans fatty acids (13) to the food industry to reduce the TFA content in soft margarines to ,2% of total fat and to ,5% of total fat in all other foods, resulted in significant reductions in TFAs in Canadian foods (15) (16) (17) . For example, most brands of soft margarines sold in Canada in the 1990s were prepared by using PHVOs and contained TFAs ranging from 20% to 25% of total fatty acids (4) (5) (6) 8) . In contrast, an increasing number of soft margarines sold since 2005 have been prepared by using nonhydrogenated vegetable oils containing ,2% TFAs (7). The food industry also has made substantial progress since 2007 in reformulating other prepackaged foods by using nonhydrogenated vegetable oils and thereby reducing the TFA content in many products (15) (16) (17) . Our study from 2005 to 2008 of the nationwide monitoring of the TFA content in retail foods, recognized in the 1990s as important contributors of TFA, found that 76% of all the prepackaged foods met the ,2% or ,5% target concentrations (16, 17) . Many fast-food restaurant chains have also been successful in decreasing TFAs in French fries, fried chicken, fried fish, fried onions, and pizzas (16, 17) . This is especially important given that the nutrition labeling regulations do not apply to foods sold in restaurants. At the end of 2008, more than 82% of the foods sampled in fastfood restaurants in the nationwide monitoring study had achieved the ,5% trans fat target in their products.
The association of the decrease of TFAs with increases in the concentrations of 9c-18:1, 18:2n26, and 18:3n23 from 1992 to 2011 human milk samples was not unexpected and consistent with the replacement of PHVOs in retail foods with high oleic oils or with a blend of high oleic oil and liquid oils such as canola (16) . This replacement is expected to decrease the TFAs and increase 9c-18:1, 18:2n26, and 18:3n23 concentrations in the Canadian diet. The lack of change in the SFA concentrations between 2009, 2010, and 2011 human milk shown in the present study further confirms that the PHVOs in retail foods were replaced by unsaturated oils, not by saturated fats and oils, such as lard, beef fat, butter, palm oil, or coconut oil.
By using the equation Y = 1.49 + 0.42X established by CraigSchmidt et al (20) for the relation between the percentage of 18:1t in milk fatty acids (Y in the equation) and the previous-day maternal diet (X in the equation), and assuming that breastfeeding mothers' intake is 2350 kcal/d, of which 30% is derived from fat (29), we estimated that TFA intakes were 4.0% of total energy, equivalent to 10.6 g/person/d, for the Canadian breastfeeding mothers who participated in our 1992 nationwide human milk study (21) . By using the same approach, we estimated that the mean (range) intake of TFAs by breastfeeding mothers in the present study was 2.3 (0-10. person/d. These data show a substantial decrease in the TFA content in the mothers' diets in the present study compared with the mothers' diets in the 1992 study. Furthermore, these values are also considerably lower than the 1.4% value of energy that we previously estimated (16) for the Canadian general population in 2008 by using TFA data of retail foods from Health Canada's Trans Fat Monitoring Program (30) and dietary intake data from the 2.2 Cycle of the Canadian Community Health Survey (31) . These estimates suggest that the concentrations of TFAs in Canadian foods are continuing to gradually decrease since our last round of surveys of Canadian foods in 2008 (16) . The estimated TFA intake values for the mothers in the present study are below the WHO's maximum recommended intake of 1% of total energy (14) .
CAD is one of the leading causes of death in Canada. In 2008, cardiovascular disease accounted for 69,500 deaths, contributing to 29% of all deaths in Canada (32) . It is well documented that TFAs adversely affect multiple CAD risk factors. TFAs lower HDL cholesterol and raise LDL cholesterol, total/HDL cholesterol ratio, lipoprotein(a), apolipoprotein B/apolipoprotein A1 ratio, C-reactive protein, and several circulating biomarkers of inflammation and endothelial dysfunction (33) . CAD risk would also be variably decreased by different fats and oils replacing TFAs from PHVOs (33) . Replacement of TFAs with MUFAs and PUFAs would reduce the CAD risk to a greater extent than by replacement of TFAs with SFAs (33) . Previously, we conservatively estimated that reduction of TFA intake to 1% of energy would prevent 12,354 heart attack cases in Canada over a 19-y period from 2010 to 2029 (17) . Providing an estimate of the CAD reduction associated with the current TFA intake concentration of 0.3% of energy estimated in this study for the Canadian breastfeeding mothers is beyond the scope of this study, but it can be safely suggested that the combined effect of a TFA intake concentration of 0.3% of energy with increased intake concentrations of MUFAs and PUFAs due to the replacement of PHVOs with liquid vegetable oils in reformulated prepackaged and restaurant foods would prevent more than 12,354 heart attacks in Canada from 2010 to 2029.
In summary, our results show a decrease in TFA concentrations in human milk, which indicates that the intake of TFAs among Canadian breastfeeding mothers has continued to decrease from 2009 to 2011. The TFA intake concentrations are lower than the maximum recommended intake concentration of 1% of energy (14) . This decrease is most likely attributed to mandatory labeling of TFAs in prepackaged foods and replacement of PHVOs with liquid vegetable oils as the frying oils in fast-food restaurants and in the preparation of retail foods by the food industry.
Potential limitations of our study should be considered. It is not known whether human milk TFA data can be generalized to the Canadian population. TFA consumption may be higher or lower in the general population. Furthermore, the MIREC study, from which the milk samples were obtained, was not population based (23) . However, the human milk samples were collected nationwide. Furthermore, in a given household, in general, all the family members, including breastfeeding mothers, eat the same foods; therefore, it can be expected that intake of TFAs, as a percentage of total fatty acids, would remain the same for the entire household.
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